- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03816579
A Meal-based Comparison of Protein Quality, Complementary Proteins and Muscle Anabolism (MAPP)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The investigators will test the following hypotheses in middle-aged men and women (45-60) years old using a randomized, cross over design. All study objectives will be met concurrently:
- Meals containing 30 g of high quality, predominantly beef-protein (PRO-A) will stimulate acute (i.e., single meal response) and 24 h skeletal muscle protein synthesis [confirmatory hypothesis]
- Meals containing 30 g of complementary plant-based proteins (PRO-B: complete essential amino acid profile at each meal) will stimulate acute and 24 h skeletal muscle protein synthesis, but to a lesser extent than beef-protein.
- A single meal containing 30 g of an incomplete plant-based protein source (PRO-C: lacking one essential amino acid) will fail to acutely stimulate skeletal muscle protein synthesis
- Meals containing 30 g of plant-based protein that are incomplete at each separate meal, but complementary over a 24 h period, will fail to stimulate 24 h skeletal muscle protein synthesis.
- Beef-and plant-based meals will have a similar effect on satiety and 24 h blood glucose [descriptive]
If these hypotheses are correct, the investigators will demonstrate that meals containing a moderate amount of high quality protein, such as beef, are an efficient and effective way to augment a largely plant based diet and stimulate skeletal muscle protein synthesis - a prerequisite for outcomes related to physical function, performance, successful aging and metabolic health.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Texas
-
Galveston, Texas, Forenede Stater, 77555
- Unversity of Texas Medical Branch
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- All races and ethnic backgrounds
- Men and women, age 45-60 years
- Generally healthy (see exclusion criteria)
- Able and willing to provide informed consent
- Ability to speak and read English (* the study procedures, e.g., muscle biopsy, duration of each acute study, e.g. overnight stay; and multiple dietary questionnaires require sound written and spoken English)
Exclusion Criteria:
- Sarcopenia (defined by: European Working Group on Sarcopenia in Older People, EWGSOP (44))
- Clinically significant heart disease (e.g. New York Heart Classification greater than grade II; ischemia)
- Peripheral vascular disease
- Pulmonary disease
- History of systemic or pulmonary embolus
- Uncontrolled blood pressure (systolic BP>170, diastolic BP>95 mmHg)
- Impaired renal function (creatinine >1.5 mg/dl)
- Anemia (hematocrit <33)
- Untreated thyroid disease (abnormal TSH)
- A recent history (<12 months) of GI bleed
- Diabetes mellitus or other untreated endocrine or metabolic disease
- Electrolyte abnormalities
- Any history of stroke, hypo- or hyper-coagulation disorders
- Recent (3 years) treated cancer other than basal cell carcinoma
- Systemic steroids, anabolic steroids, growth hormone or immunosuppressant use within 12 months
- Recent (6 months) adherence to a weight-loss or weight-gain diet
- Weight change of 5% or more in previous 6 months
- Body mass index >30 or excess body fat that compromises muscle biopsy collection
- Body mass index <20 or recent history (<12 month) of disordered eating
- Dietary preferences or practices that preclude the consumption of the study meals
- Acute infectious disease or chronic infection
- Alcohol or drug abuse
- Any other condition or event considered exclusionary by study physician
- Pregnancy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: PRO-A
Beef protein
|
30 g of beef protein will be consumed at each meal
|
Eksperimentel: PRO-B
Complementary proteins at each meal
|
30 g of complementary proteins will be consumed at each meal
|
Eksperimentel: PRO-C
Complementary proteins over 24 hours
|
30 g of complementary proteins will be consumed over 24 hours
|
Ingen indgriben: CON
Low protein (<5 g) meal
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Acute muscle protein synthesis: PRO-A
Tidsramme: 3 hours after consuming meal
|
Muscle protein synthesis response to PRO-A breakfast meal (%/h)
|
3 hours after consuming meal
|
Acute muscle protein synthesis: PRO-B
Tidsramme: 3 hours after consuming meal
|
Muscle protein synthesis response to PRO-B breakfast meal (%/h)
|
3 hours after consuming meal
|
Acute muscle protein synthesis: PRO-C
Tidsramme: 3 hours after consuming meal
|
Muscle protein synthesis response to PRO-C breakfast meal (%/h)
|
3 hours after consuming meal
|
Acute muscle protein synthesis: CON
Tidsramme: 3 hours after consuming meal
|
Muscle protein synthesis response to CON breakfast meal (%/hour)
|
3 hours after consuming meal
|
24-hour muscle protein synthesis: PRO-A
Tidsramme: Approximately 24 hours
|
Muscle protein synthesis response to PRO-A diet over 24 hours (%/hour)
|
Approximately 24 hours
|
24-hour muscle protein synthesis: PRO-B
Tidsramme: Approximately 24 hours
|
Muscle protein synthesis response to PRO-B diet over 24 hours (%/hour)
|
Approximately 24 hours
|
24-hour muscle protein synthesis: PRO-C
Tidsramme: Approximately 24 hours
|
Muscle protein synthesis response to PRO-C diet over 24 hours (%/hour)
|
Approximately 24 hours
|
Blood amino acid response to diet: PRO-A
Tidsramme: Approximately 5 hours
|
Blood samples will be drawn to measure amino acid concentrations response to PRO-A breakfast (µmol/L)
|
Approximately 5 hours
|
Blood amino acid response to diet: PRO-B
Tidsramme: Approximately 5 hours
|
Blood samples will be drawn to measure amino acid concentrations response to PRO-B breakfast (µmol/L)
|
Approximately 5 hours
|
Blood amino acid response to diet: PRO-C
Tidsramme: Approximately 5 hours
|
Blood samples will be drawn to measure amino acid concentrations response to PRO-B C breakfast (µmol/L)
|
Approximately 5 hours
|
Blood amino acid response to diet: CON
Tidsramme: Approximately 5 hours
|
Blood samples will be drawn to measure amino acid concentrations response to CON breakfast (µmol/L)
|
Approximately 5 hours
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Blood glucose response to diet: PRO-A
Tidsramme: Approximately 24 hours
|
Blood samples will be drawn to measure blood glucose response to PRO-A diet (mg/dl)
|
Approximately 24 hours
|
Blood glucose response to diet: PRO-B
Tidsramme: Approximately 24 hours
|
Blood samples will be drawn to measure blood glucose response to PRO-B diet (mg/dl)
|
Approximately 24 hours
|
Blood glucose response to diet: PRO-C
Tidsramme: Approximately 24 hours
|
Blood samples will be drawn to measure blood glucose response to PRO-C diet (mg/dl)
|
Approximately 24 hours
|
Blood glucose response to diet: CON
Tidsramme: Approximately 5 hours
|
Blood samples will be drawn to measure blood glucose response to CON breakfast meal (mg/dl)
|
Approximately 5 hours
|
Appetite and Hedonic Questionnaire: PRO-A
Tidsramme: Approximately 8 hours
|
Questionnaires will be given to assess hunger, fullness, desire to eat, thirst, desire to eat something sweet, desire to eat something salty, desire to eat something savory, sleepiness, physical energy, mental energy, and nausea in response to PRO-A diet.
All outcomes are scored individually on a 10 pt visual analog scale using "not at all" being 0 and "extremely" being a 10.
|
Approximately 8 hours
|
Appetite and Hedonic Questionnaire: PRO-B
Tidsramme: Approximately 8 hours
|
Questionnaires will be given to assess hunger, fullness, desire to eat, thirst, desire to eat something sweet, desire to eat something salty, desire to eat something savory, sleepiness, physical energy, mental energy, and nausea in response to PRO-B diet.
All outcomes are scored individually on a 10 pt visual analog scale using "not at all" being 0 and "extremely" being a 10.
|
Approximately 8 hours
|
Appetite and Hedonic Questionnaire: PRO-C
Tidsramme: Approximately 8 hours
|
Questionnaires will be given to assess hunger, fullness, desire to eat, thirst, desire to eat something sweet, desire to eat something salty, desire to eat something savory, sleepiness, physical energy, mental energy, and nausea in response to PRO-C diet.
All outcomes are scored individually on a 10 pt visual analog scale using "not at all" being 0 and "extremely" being a 10.
|
Approximately 8 hours
|
Appetite and Hedonic Questionnaire: CON
Tidsramme: Approximately 5 hours
|
Questionnaires will be given to assess hunger, fullness, desire to eat, thirst, desire to eat something sweet, desire to eat something salty, desire to eat something savory, sleepiness, physical energy, mental energy, and nausea in response to CON diet.
All outcomes are scored individually on a 10 pt visual analog scale using "not at all" being 0 and "extremely" being a 10.
|
Approximately 5 hours
|
3 day dietary record: PRO-A
Tidsramme: Approximately 36 hours
|
Diet records will be collected and analyzed with ASA24 to assess habitual energy intake the week prior to PRO-A study visit
|
Approximately 36 hours
|
3 day dietary record: PRO-B
Tidsramme: Approximately 36 hours
|
Diet records will be collected and analyzed with ASA24 to assess habitual energy intake the week prior to PRO-B study visit
|
Approximately 36 hours
|
3 day dietary record: PRO-C
Tidsramme: Approximately 36 hours
|
Diet records will be collected and analyzed with ASA24 to assess habitual energy intake the week prior to PRO-C study visit
|
Approximately 36 hours
|
3 day dietary record: CON
Tidsramme: Approximately 36 hours
|
Diet records will be collected and analyzed with ASA24 to assess habitual energy intake the week prior to CON study visit
|
Approximately 36 hours
|
Palatability Questionnaire:PRO-A
Tidsramme: Approximately 8 hours
|
Questionnaires will be given to assess palatability of the PRO-A diet.
Outcomes include the participants ranking of the food appearance, aroma intensity, aroma, flavor intensity, flavor, texture and overall appeal of the food.
A 10 pt visual analog scale will be used to assess the subject's response with 0 being "extremely dislike", 5 being "neither like nor dislike" and 10 being "extremely like".
|
Approximately 8 hours
|
Palatability Questionnaire:PRO-B
Tidsramme: Approximately 8 hours
|
Questionnaires will be given to assess palatability of the PRO-B diet.
Outcomes include the participants ranking of the food appearance, aroma intensity, aroma, flavor intensity, flavor, texture and overall appeal of the food.
A 10 pt visual analog scale will be used to assess the subject's response with 0 being "extremely dislike", 5 being "neither like nor dislike" and 10 being "extremely like".
|
Approximately 8 hours
|
Palatability Questionnaire:PRO-C
Tidsramme: Approximately 8 hours
|
Questionnaires will be given to assess palatability of the PRO-C diet.
Outcomes include the participants ranking of the food appearance, aroma intensity, aroma, flavor intensity, flavor, texture and overall appeal of the food.
A 10 pt visual analog scale will be used to assess the subject's response with 0 being "extremely dislike", 5 being "neither like nor dislike" and 10 being "extremely like".
|
Approximately 8 hours
|
Palatability Questionnaire:CON
Tidsramme: Approximately 5 hours
|
Questionnaires will be given to assess palatability of the CON diet.
Outcomes include the participants ranking of the food appearance, aroma intensity, aroma, flavor intensity, flavor, texture and overall appeal of the food.
A 10 pt visual analog scale will be used to assess the subject's response with 0 being "extremely dislike", 5 being "neither like nor dislike" and 10 being "extremely like".
|
Approximately 5 hours
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Doug Paddon-Jones, PhD, University of Texas
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 18-0147
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kost
-
Necmettin Erbakan UniversityAktiv, ikke rekrutterendeParadentose | MIDDELHAVS-DIETKalkun
Kliniske forsøg med PRO-A
-
pfm medical agAix Scientifics; Crolll Gmbh; Bayes GmbHAfsluttetCystocele | Uterin prolapsTyskland
-
Centre Hospitalier Universitaire de NīmesAfsluttet
-
Cairo UniversityUkendt
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)Rekruttering
-
Bolton MedicalAktiv, ikke rekrutterendeAortadissektion type BForenede Stater
-
United States Army Research Institute of Environmental...Eastern Michigan UniversityAfsluttetVægttab | Andre effekter af høj højdeForenede Stater
-
University of AarhusAarhus University Hospital; TrygFonden, Denmark; Sygekassernes Helsefond; Regional... og andre samarbejdspartnereAfsluttetKroniske nyresygdommeDanmark
-
Cereneo AGUniversity of Zurich; Swiss Federal Institute of Technology; Swiss Commission... og andre samarbejdspartnereAfsluttetGangtræning efter slagtilfældeSchweiz
-
University Health Network, TorontoPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied Health Research Centre og andre samarbejdspartnereAktiv, ikke rekrutterendeDysfagiForenede Stater, Canada
-
National Cancer Institute (NCI)RekrutteringProstatakræftForenede Stater